RAFAH / WAM The team from Operation Chivalrous Knight 3 on Thursday, conducted a field ...
Read More »Acorda rises 9.7 pct after getting nod for Parkinson’s therapy
Bloomberg Acorda Therapeutics Inc rose the most since October after the US Food and Drug Administration approved its therapy for Parkinson’s disease. The drug, which will be sold under the name Inbrija, is an inhaled version of levodopa, an existing therapy that treats the effects of the neurodegenerative disorder. Acorda declined to say how it plans to price the product, ...
Read More »